Network meta‐analysis of randomized trials in multiple myeloma: efficacy and safety in frontline therapy for patients not eligible for transplant

HIGHLIGHTS

• who: - Revised and collaborators from the (UNIVERSITY) have published the research: Network metau2010analysis of randomized trials in multiple myeloma: Efficacy and safety in frontline therapy for patients not eligible for transplant, in the Journal: (JOURNAL) of 26/05/2022
• what: In Supplementary Figure 1A are reported the data regarding the quality assessment: most of the study were reported as low risk in the majority of the evaluated criteria ac- 2.5 | Network metau2010analysis cording to Cochrane guidelines. On especially if sustained, is considered the best surrogate marker of these bases, the aim of the study . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.